Published in Radiology on September 01, 2010
Utilization of renal mass biopsy in patients with renal cell carcinoma. Urology (2014) 2.23
Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation. J Vasc Interv Radiol (2012) 1.33
The economic burden of incidentally detected findings. Radiol Clin North Am (2011) 1.03
Percutaneous biopsy for risk stratification of renal masses. Ther Adv Urol (2015) 0.97
Management of kidney cancer: canadian kidney cancer forum consensus update 2011. Can Urol Assoc J (2012) 0.92
Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings. J Urol (2014) 0.92
The contemporary role of renal mass biopsy in the management of small renal tumors. Front Oncol (2012) 0.81
Renal cell carcinoma needle biopsy: sowing the seed for later complications? BMJ Case Rep (2014) 0.75
Primary penile melanoma with an incidental renal oncocytoma. BMJ Case Rep (2013) 0.75
Diagnostic accuracy of contrast-enhanced ultrasound for characterization of kidney lesions in patients with and without chronic kidney disease. BMC Nephrol (2017) 0.75
Imaging the renal lesion with dual-energy multidetector CT and multi-energy applications in clinical practice: what can it truly do for you? Eur Radiol (2016) 0.75
Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA (1996) 14.23
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst (2006) 6.58
Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making (2000) 4.86
The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making (1993) 4.46
Medicare and cost-effectiveness analysis. N Engl J Med (2005) 4.20
The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol (2006) 3.88
Medicare coverage for technological innovations--time for new criteria? N Engl J Med (2004) 3.84
Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst (1995) 3.81
Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol (2001) 3.65
Solid renal tumors: an analysis of pathological features related to tumor size. J Urol (2003) 3.48
Increased incidence of serendipitously discovered renal cell carcinoma. Urology (1998) 3.35
Complications of percutaneous abdominal fine-needle biopsy. Review. Radiology (1991) 3.18
Renal mass biopsy--a renaissance? J Urol (2007) 3.12
Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis. Cancer (2008) 2.75
The natural history of incidentally detected small renal masses. Cancer (2004) 2.57
A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med (1982) 2.56
A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med (1982) 2.49
Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol (2007) 2.33
Small renal parenchymal neoplasms: further observations on growth. Radiology (1995) 2.15
Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation. Med Decis Making (2005) 2.10
Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients. Eur Urol (2009) 1.85
Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making (2002) 1.78
Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. J Urol (1999) 1.69
Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy. BJU Int (2006) 1.68
Management of the incidental renal mass. Radiology (2008) 1.66
Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol (2004) 1.63
Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer (2009) 1.60
Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol (2003) 1.59
Active surveillance of renal masses in elderly patients. J Urol (2008) 1.57
Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol (2005) 1.55
Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol (2008) 1.53
Renal masses in the adult patient: the role of percutaneous biopsy. Radiology (2006) 1.50
Trends in medical spending by age, 1963-2000. Health Aff (Millwood) (2004) 1.42
Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate. J Urol (2006) 1.40
Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol (2007) 1.36
Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome. Urology (2004) 1.35
Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol (2004) 1.31
Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol (2000) 1.26
Cost-effectiveness in a flat world--can ICDs help the United States get rhythm? N Engl J Med (2005) 1.24
Accuracy of percutaneous core biopsy in management of small renal masses. Urology (2009) 1.22
Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer (2007) 1.20
Pathological features of renal neoplasms classified by size and symptomatology. J Urol (2006) 1.15
Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology (1995) 1.13
Comparison of the descriptive epidemiology of urinary tract cancers. Cancer Causes Control (1990) 1.11
Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology (2004) 1.11
Comparison of costs and complications of radical and partial nephrectomy for treatment of localized renal cell carcinoma. Urology (2002) 1.07
Growth characteristics of renal cortical tumors in patients managed by watchful waiting. Can J Urol (2004) 1.06
Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology (2008) 1.04
Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol (2006) 1.04
Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity. Urology (1997) 1.03
Evaluation of sonographically guided percutaneous core biopsy of renal masses. AJR Am J Roentgenol (2002) 1.01
Needle tract seeding of transitional cell carcinoma following fine-needle aspiration of a renal mass. Abdom Imaging (1994) 0.98
Role of percutaneous image-guided biopsy in the evaluation of renal masses. Urol Int (2001) 0.95
Willingness to pay for a QALY: theoretical and methodological issues. Pharmacoeconomics (2005) 0.94
The role of fine needle aspiration in the assessment of renal masses. Acta Cytol (1988) 0.93
Sonographically guided renal mass biopsy: indications and efficacy. J Ultrasound Med (2001) 0.93
Diagnostic value of CT-guided biopsy of indeterminate renal masses. Clin Radiol (2004) 0.91
Pathologic findings at the time of nephrectomy for renal mass. Ann Surg Oncol (1998) 0.90
Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. AJR Am J Roentgenol (2004) 0.84
Diagnosis of renal cell carcinoma: value of fine-needle aspiration cytology in patients with metastases or contraindications to nephrectomy. AJR Am J Roentgenol (1993) 0.84
Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal masses: should we biopsy all that are indeterminate? AJR Am J Roentgenol (2007) 0.83
Percutaneous abdominal biopsy: cost-identification analysis. Radiology (1998) 0.79
Nephron-sparing surgery. Del Med J (2000) 0.77
Fine needle aspiration cytology in the diagnosis of solid renal and adrenal masses. Scand J Urol Nephrol (1985) 0.77
Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology (2003) 5.42
Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med (2012) 4.72
Bladder cancer. Lancet (2009) 4.43
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA (2004) 4.36
Adult intestinal intussusception: CT appearances and identification of a causative lead point. Radiographics (2006) 3.22
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology (2005) 3.01
Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.88
Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83
Urine leaks and urinomas: diagnosis and imaging-guided intervention. Radiographics (2003) 2.73
Paraesophageal hernias: operation or observation? Ann Surg (2002) 2.71
Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol (2012) 2.66
Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst (2004) 2.53
Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol (2005) 2.53
Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology (2003) 2.53
Acute epiploic appendagitis and its mimics. Radiographics (2005) 2.46
CT appearance of acute appendagitis. AJR Am J Roentgenol (2004) 2.39
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology (2008) 2.37
Autoimmune pancreatitis: imaging features. Radiology (2004) 2.34
Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst (2012) 2.30
Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 2.29
Clinical practice. Small renal mass. N Engl J Med (2010) 2.27
Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg (2006) 2.25
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer (2003) 2.22
Dropped appendicolith: CT findings and implications for management. AJR Am J Roentgenol (2008) 2.03
Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology (2005) 1.91
Adverse effect of paroxetine on sperm. Fertil Steril (2009) 1.90
Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. Radiology (2007) 1.87
Pheochromocytoma: an imaging chameleon. Radiographics (2004) 1.84
Transgluteal approach for percutaneous drainage of deep pelvic abscesses: 154 cases. Radiology (2003) 1.78
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78
Image-guided percutaneous splenic interventions. Radiographics (2012) 1.73
Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology (2003) 1.69
Incidence of malignancy in complex cystic renal masses (Bosniak category III): should imaging-guided biopsy precede surgery? AJR Am J Roentgenol (2003) 1.68
Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AJR Am J Roentgenol (2009) 1.68
Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology (2004) 1.62
The IR RadLex project: an interventional radiology lexicon--a collaborative project of the Radiological Society of North America and the Society of Interventional Radiology. J Vasc Interv Radiol (2008) 1.61
Impact of obesity on medical imaging and image-guided intervention. AJR Am J Roentgenol (2007) 1.58
Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol (2008) 1.57
Abdominopelvic CT increases diagnostic certainty and guides management decisions: a prospective investigation of 584 patients in a large academic medical center. AJR Am J Roentgenol (2011) 1.56
Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Ann Thorac Surg (2008) 1.56
Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med (2012) 1.52
Reorganizing the system of care surrounding laparoscopic surgery: a cost-effectiveness analysis using discrete-event simulation. Med Decis Making (2004) 1.51
Percutaneous ablation in the kidney. Radiology (2011) 1.51
Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics (2009) 1.48
A noninvasive multi-analyte diagnostic assay: combining protein and DNA markers to stratify bladder cancer patients. Res Rep Urol (2012) 1.48
Percutaneous lung biopsy in a patient with a cavitating lung mass: indications, technique, and complications. AJR Am J Roentgenol (2005) 1.44
Extraadrenal pheochromocytoma: a rare cause of tachycardia and hypertension during percutaneous biopsy. AJR Am J Roentgenol (2005) 1.44
Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol (2008) 1.42
ACR Appropriateness Criteria® Multiple gestations. Ultrasound Q (2012) 1.40
Watchful waiting for localized prostate cancer in the PSA era: what have been the triggers for intervention? BJU Int (2010) 1.40
Rare benign and malignant appendiceal lesions: spectrum of computed tomography findings with pathologic correlation. J Comput Assist Tomogr (2003) 1.38
Penis Transplantation: First US Experience. Ann Surg (2017) 1.38
Current concepts in lymph node imaging. J Nucl Med (2004) 1.38
ACR Appropriateness Criteria® clinically suspected adnexal mass. Ultrasound Q (2013) 1.38
Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain. AJR Am J Roentgenol (2008) 1.37
CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics (2011) 1.36
Algorithmic approach to CT diagnosis of the abnormal bowel wall. Radiographics (2002) 1.36
A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. J Card Fail (2006) 1.36
Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol (2005) 1.34
Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain. J Am Coll Cardiol (2009) 1.34
Percutaneous hepatic abscess drainage: do multiple abscesses or multiloculated abscesses preclude drainage or affect outcome? J Vasc Interv Radiol (2009) 1.34
Imaging diagnosis of cystic pancreatic lesions: pseudocyst versus nonpseudocyst. Radiographics (2005) 1.32
Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions. AJR Am J Roentgenol (2008) 1.28
Calibration of disease simulation model using an engineering approach. Value Health (2009) 1.27
Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer (2008) 1.26
Cost-effectiveness of whole-body CT screening. Radiology (2005) 1.25
Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations. Value Health (2008) 1.24
Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol (2006) 1.23
Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol (2005) 1.22
Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value Health (2011) 1.22
Effect of obesity on image quality: fifteen-year longitudinal study for evaluation of dictated radiology reports. Radiology (2006) 1.22
Sensitive multiplexed analysis of kinase activities and activity-based kinase identification. Nat Biotechnol (2009) 1.21
MR imaging of the acute abdomen and pelvis: acute appendicitis and beyond. Radiographics (2007) 1.20
Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proc Natl Acad Sci U S A (2010) 1.20
Prospective evaluation of MR enterography as the primary imaging modality for pediatric Crohn disease assessment. AJR Am J Roentgenol (2011) 1.20
Radiation dose reduction with hybrid iterative reconstruction for pediatric CT. Radiology (2012) 1.19
Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol (2009) 1.18
Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience. Radiology (2006) 1.17
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2007) 1.16
Cystic lymph node metastases in papillary thyroid carcinoma. AJR Am J Roentgenol (2002) 1.16